AnaptysBio (ANAB)
(Delayed Data from NSDQ)
$35.71 USD
+2.01 (5.96%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $35.72 +0.01 (0.03%) 6:44 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -1.08 |
EPS Last Quarter | -1.64 |
Last EPS Surprise | -6.49% |
ABR | 1.36 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -6.04 |
Next Year | -6.49 |
EPS (TTM) | -6.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 31.06M | 6.40M | 36.63M | 27.06M |
# of Estimates | 4 | 4 | 6 | 4 |
High Estimate | 57.00M | 7.91M | 79.18M | 46.80M |
Low Estimate | 6.70M | 3.00M | 7.18M | 12.00M |
Year ago Sales | 3.46M | 3.32M | 17.16M | 36.63M |
Year over Year Growth Est. | 797.69% | 92.83% | 113.50% | -26.14% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.08 | -1.69 | -6.04 | -6.49 |
# of Estimates | 6 | 6 | 6 | 7 |
Most Recent Consensus | -1.53 | -1.58 | -6.30 | -6.61 |
High Estimate | 0.11 | -1.58 | -5.08 | -4.73 |
Low Estimate | -1.73 | -1.79 | -6.83 | -7.50 |
Year ago EPS | -1.50 | -1.41 | -6.08 | -6.04 |
Year over Year Growth Est. | 28.00% | -19.86% | 0.66% | -7.47% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.08 | -1.69 | -6.04 | -6.49 |
7 Days Ago | -1.08 | -1.69 | -6.04 | -6.49 |
30 Days Ago | -1.08 | -1.69 | -6.04 | -6.49 |
60 Days Ago | -1.34 | -1.63 | -6.14 | -6.38 |
90 Days Ago | -1.53 | -1.50 | -6.13 | -5.94 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.08 | -1.69 | -6.04 | -6.49 |
Zacks Consensus Estimate | -1.08 | -1.69 | -6.04 | -6.49 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.64 | -1.59 | -1.41 | -1.50 | NA |
Estimate | -1.54 | -1.74 | -1.72 | -1.65 | NA |
Difference | -0.10 | 0.15 | 0.31 | 0.15 | 0.13 |
Surprise | -6.49% | 8.62% | 18.02% | 9.09% | 7.31% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more